Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
EpicentRx, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically or cytologically confirmed diagnosis of biliary tract adenocarcinoma/cholangiocarcinoma
Must have locally advanced or distant metastatic disease that is not surgically curable
Failed first-line chemotherapy
Age ≥ 18 years
Life expectancy of at least 12 weeks (3 months)
Performance status 0 or 1
Adequate liver, kidney, and bone marrow function
You may not be if
Symptomatic metastatic brain or meningeal tumors
Investigational compound within 4 weeks of enrollment
History of needing to permanently discontinue prior gemcitabine/ cisplatin regimen for reasons other than progression (i.e. toxicity)
Any medical condition which, in the investigator's opinion, makes the patient unsuitable for participation
Pregnant or nursing
Substance abuse, medical, psychological or social conditions that may interfere with the subject's participation in the study or evaluation of the study results
Albumin \<2.8
Uncontrolled or clinically relevant ascites
Absolute contraindication for MRI imaging such as intracorporeal metal or pacemaker
